Health Care & Life Sciences » Pharmaceuticals | Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.97
Market Cap
$97.4 M
Shares Outstanding
41.27 M
Public Float
33.85 M

Profile

Address
640 Lee Road
Malvern Pennsylvania 19087
United States
Employees -
Website http://www.aclaristx.com
Updated 07/08/2019
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.

Financials

View All

Neal S. Walker
President, Chief Executive Officer & Director
Stephen A. Tullman
Chairman